More than 10 analysts turned bullish on at least 4 of the stocks.
Related Posts
Novo Nordisk’s next-gen obesity drug CagriSema had investors excited. Now they’re not so sure
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial […]
Ancora, Norfolk Southern strike settlement deal to avert proxy fight
Norfolk Southern and activist investor Ancora struck a deal to avert a proxy fight at the railroad.
MongoDB plummets 20% as weak outlook overshadows strong quarterly results
MongoDB shares plummeted more than 20% after the database software maker shared weak guidance that signaled a slowdown in growth.